Financials

  • Market Capitalization 9.19 M
  • Employee 2
  • Founded 1997
  • CEO N/A
  • Website www.xeneticbio.com
  • Headquarter Nevada, United States
  • FIGI BBG0028WJXC0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.37
Price to sales ratio
1.24

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4770
GDTC
CytoMed Therapeutics Limited - Ordinary Shares
0.86 USD-9.47%0.00%-4.44%-57.21%10.17 M USD
4787
FBLG
FibroBiologics, Inc. - Common Stock
1.44 USD-3.36%0.00%+128.57%+128.57%9.59 M USD
4803
IMNN
Imunon, Inc. - Common Stock
1.58 USD-1.25%-3.66%+5.33%-51.38%8.87 M USD
4804
TRAW
Traws Pharma, Inc. - Common Stock
0.58 USD-1.69%+9.43%+16.00%-59.15%8.91 M USD

Frequently asked questions about Xenetic Biosciences, Inc.

What is the Xenetic Biosciences, Inc. stock price today?

The current price of Xenetic Biosciences, Inc. (XBIO) is 3.92. Over the past 24 hours, the stock has changed by -1.26%. Follow the XBIO chart for real-time price dynamics.

What is the stock ticker of Xenetic Biosciences, Inc.?

Xenetic Biosciences, Inc. trades under the ticker XBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Xenetic Biosciences, Inc. stock going up?

XBIO has changed by +12.32% over the last week, +54.94% over the last month, and +37.54% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Xenetic Biosciences, Inc.?

Xenetic Biosciences, Inc. currently has a market capitalization of 9.19 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Xenetic Biosciences, Inc. earnings last quarter?

Last quarter, Xenetic Biosciences, Inc. reported earnings of -0.41 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Xenetic Biosciences, Inc. revenue for the last quarter?

Xenetic Biosciences, Inc. reported quarterly revenue of 660.6 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Xenetic Biosciences, Inc. net income for the last quarter?

Xenetic Biosciences, Inc. reported net income of -929.69 K for the last quarter. The previous quarter showed -456.38 K, which means net income changed by -103.71%.

How many employees does Xenetic Biosciences, Inc. have?

As of the latest available data, Xenetic Biosciences, Inc. has 2 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Xenetic Biosciences, Inc. stock?

You can buy Xenetic Biosciences, Inc. (XBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Xenetic Biosciences, Inc. stock?

Investing in Xenetic Biosciences, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XBIO chart and related analysis on metatrader.com as part of your research.

News